Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Implementing emicizumab in hemophilia inhibitor management: emicizumab should be prescribed after tolerance.

Literature DB >> 30352951

Implementing emicizumab in hemophilia inhibitor management: emicizumab should be prescribed after tolerance.

Guy Young¹.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2018 PMID： 30352951 PMCID： PMC6199657 DOI： 10.1182/bloodadvances.2018015842

Source DB: PubMed Journal: Blood Adv ISSN： 2473-9529

× No keyword cloud information.

14 in total

1. The principal results of the International Immune Tolerance Study: a randomized dose comparison.

Authors: Charles R M Hay; Donna M DiMichele
Journal: Blood Date: 2011-11-18 Impact factor: 22.113

2. AAV5-Factor VIII Gene Transfer in Severe Hemophilia A.

Authors: Savita Rangarajan; Liron Walsh; Will Lester; David Perry; Bella Madan; Michael Laffan; Hua Yu; Christian Vettermann; Glenn F Pierce; Wing Y Wong; K John Pasi
Journal: N Engl J Med Date: 2017-12-09 Impact factor: 91.245

Review 3. The past and future of haemophilia: diagnosis, treatments, and its complications.

Authors: Flora Peyvandi; Isabella Garagiola; Guy Young
Journal: Lancet Date: 2016-02-18 Impact factor: 79.321

4. Physical functioning in boys with hemophilia in the U.S.

Authors: Paul E Monahan; Judith R Baker; Brenda Riske; J Michael Soucie
Journal: Am J Prev Med Date: 2011-12 Impact factor: 5.043

5. Impact of inhibitors on hemophilia A mortality in the United States.

Authors: Christopher E Walsh; J Michael Soucie; Connie H Miller
Journal: Am J Hematol Date: 2015-02-05 Impact factor: 10.047

6. Factor VIII inhibitors in hemophilia A: rationale and latest evidence.

Authors: Char Witmer; Guy Young
Journal: Ther Adv Hematol Date: 2013-02

Review 7. Gene therapy for immune tolerance induction in hemophilia with inhibitors.

Authors: V R Arruda; B J Samelson-Jones
Journal: J Thromb Haemost Date: 2016-05-14 Impact factor: 5.824

8. Deaths in Swedish hemophiliacs, 1957-1980.

Authors: S A Larsson; B Wiechel
Journal: Acta Med Scand Date: 1983

9. Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV.

Authors: Sarah C Darby; Sau Wan Kan; Rosemary J Spooner; Paul L F Giangrande; Frank G H Hill; Charles R M Hay; Christine A Lee; Christopher A Ludlam; Michael Williams
Journal: Blood Date: 2007-04-19 Impact factor: 22.113

10. Factors predictive of death among HIV-uninfected persons with haemophilia and other congenital coagulation disorders.

Authors: L S Diamondstone; L M Aledort; J J Goedert
Journal: Haemophilia Date: 2002-09 Impact factor: 4.287

8 in total

1. Emicizumab use in major orthopedic surgery.

Authors: Craig D Seaman; Margaret V Ragni
Journal: Blood Adv Date: 2019-06-11

2. Origins and organization of the NHLBI State of the Science Workshop: Generating a national blueprint for future research on factor VIII inhibitors.

Authors: Denise E Sabatino; Steven W Pipe; Diane J Nugent; J Michael Soucie; W Craig Hooper; W Keith Hoots; Donna M DiMichele
Journal: Haemophilia Date: 2019-07 Impact factor: 4.287

Review 3. Translational Potential of Immune Tolerance Induction by AAV Liver-Directed Factor VIII Gene Therapy for Hemophilia A.

Authors: Benjamin J Samelson-Jones; Valder R Arruda
Journal: Front Immunol Date: 2020-04-28 Impact factor: 7.561